Abstract
Between January 1982 and December 1983 14,666 high-risk individuals in the Canton of Zurich, which has one million inhabitants, received 36,234 hepatitis B vaccine injections. The annual number of acute hepatitis B cases dropped from an estimated 220 to 280 in 1981 to 177 in 1982 and 133 in 1983. This drop of 40–50 % resulted mainly from reduced numbers of cases among health care workers, drug addicts and homosexuals. Vaccination was a factor responsible for the reduced incidence of hepatitis B among health care workers and drug addicts, high-risk categories substantial proportions of which had been vaccinated. There was no evidence of a secondary protective effect of vaccination extending to other high-risk groups.
Similar content being viewed by others
References
Grob, P. J., Rickenbach, M., Wagner, S., Steffen, R., Gutzwiller, F.: Hepatitis B vaccination of high-risk individuals in the Canton of Zurich. European Journal of Clinical Microbiology 1983, 2: 309–315.
Widmer, U. K., Villaverde, A., Grob, P. J.: Hepatitisepidemiologie 1977 bis 1979. Schweizerische Medizinische Wochenschrift 1980, 110: 930–937.
Advisory Committee of Immunization Practices: Inactivated hepatitis B virus vaccine. Morbidity and Mortality Weekly Report 1982, 31: 317–322, 327–329.
Grob, P. J.: The significance of hepatitis B infection in patients on hemodialysis or with renal transplants. In: Krugman, S., Sherlock, S. (ed.): Proceedings of the European Symposium on Hepatitis B. Merck, Sharp & Dohme International, New York, 1981, p. 39–53.
Blumer, U., Schär, M., Grob, P. J.: Gassenimpfung. Sozialund Präventivmedizin 1984, 29: 187–188.
Grob, P. J., Binswanger, U., Zaxuba, K., Joller-Jemelka, H. I., Schmid, M., Häcki, W., Blumberg, A., Abplanalp, A., Herwig, W., Iselin, H., Descoeudres, C.: Immunogenicity of a hepatitis B subunit vaccine in hemodialysis and in renal transplant recipients. Antiviral Research 1983, 3: 43–52.
Szmuness, W., Stevens, C. E., Harley, E. J., Zang, E. A., Oleszko, W. R., William, D. C., Sadovsky, R., Morrison, J. M., Kellner, A.: Hepatitis B vaccine. Demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. New England Journal of Medicine 1980, 303: 833–841.
Crosnier, J., Jungers, P., Couccoucé, A. M., Laplanche, A., Benhamou, E., Degos, F., Lacour, B., Prunet, P., Cerisier, Y., Guesry, P.: Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in French haemodialysis units. II: Haemodialysis patients. Lancet 1981, i: 797–800.
Desmyter, J., De Groote, G., Colaert, J.: Efficacy of heat-inactivated hepatitis B vaccine in haemodialysis patients and staff. Lancet 1983, ii: 1323–1328.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Grob, P.J., Rickenbach, M., Steffen, R. et al. Hepatitis B vaccination campaign in a low endemicity area. Eur. J, Clin. Microbiol. 4, 408–411 (1985). https://doi.org/10.1007/BF02148694
Issue Date:
DOI: https://doi.org/10.1007/BF02148694